Pharmaceutical Executive October 18, 2024
Mike Hollan

The company includes the technology in drug development, improving efficiency, and other areas.

Over the past few years, AI has become one of the most discussed technologies. The algorithm and machine-learning software makes it possible for data to be sorted, analyzed, and arranged on much fast timelines than previously thought possible. For the pharmaceutical industry, this has made the technology very valuable, due to the high amount of varied pieces of data that the industry relies upon.

Johnson & Johnson recently issued a press release detailing six of the ways that it incorporates AI into its various processes.

Jim Swanson, executive vice president and chief information officer at Johnson & Johnson, said in the press release, “In the next few...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article